These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35607308)

  • 1. The Expression and Survival Significance of FOXD1 in Lung Squamous Cell Carcinoma: A Meta-Analysis, Immunohistochemistry Validation, and Bioinformatics Analysis.
    Xie F; Li Y; Liang B
    Biomed Res Int; 2022; 2022():7798654. PubMed ID: 35607308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.
    Huang J; Liang B; Wang T
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of
    Lin H; Wang J; Shi Q; Wu M
    PeerJ; 2024; 12():e17338. PubMed ID: 38708353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four hub genes regulate tumor infiltration by immune cells, antitumor immunity in the tumor microenvironment, and survival outcomes in lung squamous cell carcinoma patients.
    Zhang T; Yang H; Sun B; Yao F
    Aging (Albany NY); 2021 Jan; 13(3):3819-3842. PubMed ID: 33428598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of lung squamous cell carcinoma immune microenvironment and immunotherapy efficiency with pyroptosis-derived genes.
    Deng X; Wang Z; Luo Y; Li Z; Chen L
    Medicine (Baltimore); 2022 Sep; 101(37):e30304. PubMed ID: 36123889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of RNMT as an immunotherapeutic and prognostic biomarker: From pan-cancer analysis to lung squamous cell carcinoma validation.
    Huang S; Tan C; Zheng J; Huang Z; Li Z; Lv Z; Chen W; Chen M; Yuan X; Chen C; Yan Q
    Immunobiology; 2024 Sep; 229(5):152836. PubMed ID: 39018675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma.
    Liang H; Zhang C; Li C; Li C; Wang Y; Lin H
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34028536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMP12 serves as an immune cell-related marker of disease status and prognosis in lung squamous cell carcinoma.
    Zhang W; Li GS; Gan XY; Huang ZG; He RQ; Huang H; Li DM; Tang YL; Tang D; Zou W; Liu J; Dang YW; Chen G; Zhou HF; Kong JL; Lu HP
    PeerJ; 2023; 11():e15598. PubMed ID: 37601247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analyses of a CD8
    Chen L; Weng Y; Cui X; Li Q; Peng M; Song Q
    BMC Bioinformatics; 2023 Jun; 24(1):238. PubMed ID: 37280525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
    Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
    Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Exploration of the Perturbation of PKIG in Lung Squamous Cell Carcinoma and the Role in Tumor Microenvironment Based on Bioinformatics Method].
    Liu Q; Li H; Li B; Ren M; Li Z; Chen Y; Zheng Z; Meng Y; Feng H
    Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):523-537. PubMed ID: 37653016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exploring the Role of PCDHGB4 in the Occurrence of Lung Squamous Cell Carcinoma Based on Bioinformatics Analysis].
    Lu R; Abuduhailili X; Li Y; Ning J; Feng Y
    Zhongguo Fei Ai Za Zhi; 2024 Mar; 27(3):199-215. PubMed ID: 38590195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
    Tian WJ; Liu SS; Li BR
    Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma.
    Xu F; Zhang H; Chen J; Lin L; Chen Y
    Int Immunopharmacol; 2020 Apr; 81():105932. PubMed ID: 31836430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
    Ke D; Guo Q; Fan TY; Xiao X
    Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
    Diao X; Guo C; Liu L; Wang G; Li S
    Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
    Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
    Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXD1 Promotes Cell Growth and Metastasis by Activation of Vimentin in NSCLC.
    Li D; Fan S; Yu F; Zhu X; Song Y; Ye M; Fan L; Lv Z
    Cell Physiol Biochem; 2018; 51(6):2716-2731. PubMed ID: 30562753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the Immune Microenvironmental Landscape of Lung Squamous Cell Carcinoma with Immune Cell Infiltration.
    Chen C; Tang D; Gu C; Wang B; Yao Y; Wang R; Zhang H; Gao W
    Dis Markers; 2022; 2022():2361507. PubMed ID: 36411824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma.
    Liu Z; Wan Y; Qiu Y; Qi X; Yang M; Huang J; Zhang Q
    Int J Med Sci; 2020; 17(10):1393-1405. PubMed ID: 32624696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.